Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 556

1.

Dynasore disrupts trafficking of herpes simplex virus proteins.

Mues MB, Cheshenko N, Wilson DW, Gunther-Cummins L, Herold BC.

J Virol. 2015 Jul;89(13):6673-84. doi: 10.1128/JVI.00636-15. Epub 2015 Apr 15.

PMID:
25878109
2.

Novel rat models to study primary genital herpes simplex virus-2 infection.

Önnheim K, Ekblad M, Görander S, Lange S, Jennische E, Bergström T, Wildt S, Liljeqvist JÅ.

Arch Virol. 2015 May;160(5):1153-61. doi: 10.1007/s00705-015-2365-7. Epub 2015 Feb 21.

PMID:
25701211
3.

Herpes simplex virus infection during pregnancy.

Stephenson-Famy A, Gardella C.

Obstet Gynecol Clin North Am. 2014 Dec;41(4):601-14. doi: 10.1016/j.ogc.2014.08.006. Epub 2014 Oct 5. Review.

PMID:
25454993
4.

A single intramuscular vaccination of mice with the HSV-1 VC2 virus with mutations in the glycoprotein K and the membrane protein UL20 confers full protection against lethal intravaginal challenge with virulent HSV-1 and HSV-2 strains.

Stanfield BA, Stahl J, Chouljenko VN, Subramanian R, Charles AS, Saied AA, Walker JD, Kousoulas KG.

PLoS One. 2014 Oct 28;9(10):e109890. doi: 10.1371/journal.pone.0109890. eCollection 2014.

5.

[Immune diagnostics of disorders in the IFN-alpha/NK-cell system in patients with frequently recurrent herpes simplex].

Karsonova AV, Shulzhenko AE, Karaulov AV.

Zh Mikrobiol Epidemiol Immunobiol. 2014 May-Jun;(3):27-34. Russian.

PMID:
25286509
6.

Genital herpes.

Garland SM, Steben M.

Best Pract Res Clin Obstet Gynaecol. 2014 Oct;28(7):1098-110. doi: 10.1016/j.bpobgyn.2014.07.015. Epub 2014 Aug 4. Review.

PMID:
25153069
7.

Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.

Le Cleach L, Trinquart L, Do G, Maruani A, Lebrun-Vignes B, Ravaud P, Chosidow O.

Cochrane Database Syst Rev. 2014 Aug 3;8:CD009036. doi: 10.1002/14651858.CD009036.pub2. Review.

PMID:
25086573
8.

[Vaccines as an approach to the immunocorrection in herpetic infections].

Barinskiĭ IF, Alimbarova LM, Lazarenko AA, Makhmudov FR, Sergeev OV.

Vopr Virusol. 2014 Jan-Feb;59(1):5-11. Review. Russian.

PMID:
25065139
9.
10.

HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).

Schulte JM, Bellamy AR, Hook EW 3rd, Bernstein DI, Levin MJ, Leone PA, Sokol-Anderson ML, Ewell MG, Wolff PA, Heineman TC, Belshe RB.

South Med J. 2014 Feb;107(2):79-84. doi: 10.1097/SMJ.0000000000000062.

PMID:
24926671
11.

Diagnosis of genital herpes simplex virus infection in the clinical laboratory.

LeGoff J, Péré H, Bélec L.

Virol J. 2014 May 12;11:83. doi: 10.1186/1743-422X-11-83. Review.

12.

Population-based surveillance of neonatal herpes simplex virus infection in Australia, 1997-2011.

Jones CA, Raynes-Greenow C, Isaacs D; Neonatal HSV Study Investigators and Contributors to the Australian Paediatric Surveillance Unit.

Clin Infect Dis. 2014 Aug 15;59(4):525-31. doi: 10.1093/cid/ciu381. Epub 2014 May 20.

13.

Detection of herpes simplex and varicella-zoster virus in clinical specimens by multiplex real-time PCR and melting curve analysis.

Hong YJ, Lim MS, Hwang SM, Kim TS, Park KU, Song J, Kim EC.

Biomed Res Int. 2014;2014:261947. doi: 10.1155/2014/261947. Epub 2014 Apr 16.

14.

Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.

Samandary S, Kridane-Miledi H, Sandoval JS, Choudhury Z, Langa-Vives F, Spencer D, Chentoufi AA, Lemonnier FA, BenMohamed L.

Hum Immunol. 2014 Aug;75(8):715-29. doi: 10.1016/j.humimm.2014.04.016. Epub 2014 May 4.

15.

Evaluation of non-extracted genital swabs for real-time HSV PCR.

Miari VF, Wall GR, Clark DA.

J Med Virol. 2015 Jan;87(1):125-9. doi: 10.1002/jmv.23967. Epub 2014 May 2.

PMID:
24788593
16.

[Anti-herpetic effect of photodynamic action in an in vitro experiment].

Makarov OV, Khashukaeva AZ, Svitich OA, Markova ÈA, Khlynova SA, Labzhinov PA, Zverev VV.

Zh Mikrobiol Epidemiol Immunobiol. 2014 Jan-Feb;(1):48-55. Russian.

PMID:
24738294
17.

Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine.

Awasthi S, Belshe RB, Friedman HM.

J Infect Dis. 2014 Aug 15;210(4):571-5. doi: 10.1093/infdis/jiu177. Epub 2014 Mar 20.

18.

Pediatric herpes simplex virus infections: an evidence-based approach to treatment.

Sanders JE, Garcia SE.

Pediatr Emerg Med Pract. 2014 Jan;11(1):1-19; quiz 19. Review.

PMID:
24649621
19.

Epidemiology of genital herpes simplex virus type 1 and 2 infections in southwestern Finland during a 10-year period (2003-2012).

Kortekangas-Savolainen O, Orhanen E, Puodinketo T, Vuorinen T.

Sex Transm Dis. 2014 Apr;41(4):268-71. doi: 10.1097/OLQ.0000000000000101.

PMID:
24622640
20.

Mimicking herpes simplex virus 1 and herpes simplex virus 2 mucosal behavior in a well-characterized human genital organ culture.

Steukers L, Weyers S, Yang X, Vandekerckhove AP, Glorieux S, Cornelissen M, Van den Broeck W, Temmerman M, Nauwynck HJ.

J Infect Dis. 2014 Jul 15;210(2):209-13. doi: 10.1093/infdis/jiu036. Epub 2014 Jan 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk